Peter Lynch · Growth at a reasonable price (GARP)
Is Aurinia Pharmaceuticals Inc. (AUPH) a Peter Lynch Stock?
Strong GARP candidate: growth at a reasonable price.
81/100
Encaja
4/6 criterios cumplidos
Los criterios de Peter Lynch, aplicados a AUPH
PEG ≤ 1.0
clave-
EPS CAGR ≥ 15%
clave-
Revenue CAGR ≥ 10%
57.8%
Net margin > 0
100.0%
Cómo se valora AUPH en otras estrategias
Datos financieros en vivo
Cap. mercado
$2.11B
PER (TTM)
6.8x
ROIC (TTM)
18.99%
Margen bruto
89.74%
Otros análisis Peter Lynch
Preguntas frecuentes
What is AUPH's Peter Lynch fit score?
AUPH scores 81/100 on our Peter Lynch fit engine. Strong GARP candidate: growth at a reasonable price.
Does Peter Lynch actually own AUPH?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends AUPH.
How often is this score updated?
AUPH's Peter Lynch fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Peter Lynch posea o recomiende AUPH personalmente.
